These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


793 related items for PubMed ID: 19429976

  • 1. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ, Surace EI, Cambell M, Higgins RJ, Leutenegger CM, Bollen AW, LeCouteur RA, Gutmann DH.
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [Abstract] [Full Text] [Related]

  • 2. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
    Nunes F, Shen Y, Niida Y, Beauchamp R, Stemmer-Rachamimov AO, Ramesh V, Gusella J, MacCollin M.
    Cancer Genet Cytogenet; 2005 Oct 15; 162(2):135-9. PubMed ID: 16213361
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R, Waha A, Vogel Y, Lenartz D, Schramm J, Wiestler OD, von Deimling A.
    Lab Invest; 1997 Dec 15; 77(6):601-6. PubMed ID: 9426397
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
    Begnami MD, Rushing EJ, Santi M, Quezado M.
    Int J Surg Pathol; 2007 Apr 15; 15(2):110-5. PubMed ID: 17478763
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of beta-catenin/E-cadherin in meningiomas.
    Brunner EC, Romeike BF, Jung M, Comtesse N, Meese E.
    Histopathology; 2006 Aug 15; 49(2):178-87. PubMed ID: 16879395
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.
    Martinez-Glez V, Bello MJ, Franco-Hernandez C, De Campos JM, Isla A, Vaquero J, Rey JA.
    Int J Mol Med; 2005 Oct 15; 16(4):771-4. PubMed ID: 16142420
    [Abstract] [Full Text] [Related]

  • 7. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.
    Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH.
    J Neuropathol Exp Neurol; 2004 Oct 15; 63(10):1015-27. PubMed ID: 15535129
    [Abstract] [Full Text] [Related]

  • 8. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K, Piaskowski S, Gresner SM, Golanska E, Bieniek E, Bigoszewska K, Sikorska B, Szybka M, Kulczycka-Wojdala D, Zakrzewska M, Zawlik I, Papierz W, Stawski R, Jaskolski DJ, Och W, Sieruta M, Liberski PP, Rieske P.
    Cancer Genet Cytogenet; 2008 May 15; 183(1):14-20. PubMed ID: 18474292
    [Abstract] [Full Text] [Related]

  • 9. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
    Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247
    [Abstract] [Full Text] [Related]

  • 10. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH, Kim IS, Kwon SY, Jang BC, Suh SI, Shin DH, Jeon CH, Son EI, Kim SP.
    Int J Mol Med; 2006 Jul 01; 18(1):27-32. PubMed ID: 16786152
    [Abstract] [Full Text] [Related]

  • 11. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
    Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA.
    Neurosurgery; 2008 Oct 01; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
    [Abstract] [Full Text] [Related]

  • 12. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
    Ding YS, Wang HD, Tang K, Hu ZG, Jin W, Yan W.
    Ann Clin Lab Sci; 2008 Oct 01; 38(4):344-51. PubMed ID: 18988927
    [Abstract] [Full Text] [Related]

  • 13. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
    Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR.
    J Neurosurg; 1998 Mar 01; 88(3):562-9. PubMed ID: 9488313
    [Abstract] [Full Text] [Related]

  • 14. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
    Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M.
    J Neurosurg; 2001 Jan 01; 94(1):111-7. PubMed ID: 11147878
    [Abstract] [Full Text] [Related]

  • 15. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
    Girish V, Sachdeva N, Minz RW, Radotra B, Mathuria SN, Arora SK.
    Indian J Pathol Microbiol; 2005 Jul 01; 48(3):325-30. PubMed ID: 16761743
    [Abstract] [Full Text] [Related]

  • 16. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
    Taylor F, Murphy S, Hoather T, Dobson J, Scase T.
    Vet Comp Oncol; 2010 Dec 01; 8(4):263-72. PubMed ID: 21062408
    [Abstract] [Full Text] [Related]

  • 17. NF2: the wizardry of merlin.
    Xiao GH, Chernoff J, Testa JR.
    Genes Chromosomes Cancer; 2003 Dec 01; 38(4):389-99. PubMed ID: 14566860
    [Abstract] [Full Text] [Related]

  • 18. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
    van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC.
    J Pathol; 2006 Mar 01; 208(4):564-73. PubMed ID: 16353169
    [Abstract] [Full Text] [Related]

  • 19. Expression of cell adhesion molecules and doublecortin in canine anaplastic meningiomas.
    Ide T, Uchida K, Suzuki K, Kagawa Y, Nakayama H.
    Vet Pathol; 2011 Jan 01; 48(1):292-301. PubMed ID: 21123860
    [Abstract] [Full Text] [Related]

  • 20. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
    Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF.
    Hum Mol Genet; 2000 Jun 12; 9(10):1495-500. PubMed ID: 10888600
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.